Investing Profile

Sanne Weijzen

InvestorVC
Partner at Aglaia Oncology Funds
Photo of Sanne Weijzen, Partner at Aglaia Oncology Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
AstraZeneca Network
19 CONNECTIONS
Leiden University Network
15 CONNECTIONS
$100K - $5.0M
$1.5M
Post-doc Dept. of Physiological Chemistry UMC UtrechtPresent
Business Analyst Aglaia Oncology FundsPresent
Investment Manager Aglaia Oncology FundsPresent
Member of the Supervisory Board InteRNA Technologies BVPresent
Ad-interim Chairman of the Supervisory Board InteRNA Technologies BVPresent
Owner HotmailPresent
COO Scenic BiotechPresent
VP, Head of Corporate Strategy and Global Operations Neogene TherapeuticsPresent
Member of The Supervisory Board HotmailPresent
Head of Corporate Strategy, Cell Therapy AstraZenecaPresent
Partner Aglaia Oncology FundsPresent
Leiden University Master of Science - MS Biomedical Sciences
Thoraxcenter, Erasmus University Medical Center PhD Cancer Immunology/Tumor Biology